APO Research
Talk to an analyst

APO RESEARCH · REPORT

Piroxicam API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Piroxicam API Industry Growth and Trends Forecast to 2032

22 December 2025107 pages

Choose your research edition.

Industry ResearchPiroxicam API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Piroxicam API Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Piroxicam API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Piroxicam API Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Piroxicam API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Piroxicam API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Piroxicam API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Piroxicam API include Nostrum, SK Chemicals, Pidi Pharmaceutical, Pfizer, Jumpcan Pharmaceutical, Jiangxi Pharmaceutical, Mylan, Maoxiang Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Piroxicam API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Piroxicam API market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Piroxicam API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Piroxicam API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Piroxicam API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Piroxicam API Market by Company

Nostrum

SK Chemicals

Pidi Pharmaceutical

Pfizer

Jumpcan Pharmaceutical

Jiangxi Pharmaceutical

Mylan

Maoxiang Pharmaceutical

Teva

Viwit Pharmaceutical

XinAn Pharmaceutical

Changjiang Pharmaceutical

Piroxicam API Segment by Type

Purity≥ 99%

Purity≥ 99.5%

Piroxicam API Segment by Application

Injection

Ointment

Tablets

Capsule

Piroxicam API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Piroxicam API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Piroxicam API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Piroxicam API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Piroxicam API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Piroxicam API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity≥ 99% Table 2. Major Company of Purity≥ 99.5% Table 3. Global Piroxicam API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Piroxicam API Sales by Type (2021-2026) & (k units) Table 5. Global Piroxicam API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Piroxicam API Sales Market Share in Value by Type (2021-2026) Table 8. Global Piroxicam API Price by Type (2021-2026) & (US$/unit) Table 9. Global Piroxicam API Sales by Type (2027-2032) & (k units) Table 10. Global Piroxicam API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Piroxicam API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Piroxicam API Sales Market Share in Value by Type (2027-2032) Table 13. Global Piroxicam API Price by Type (2027-2032) & (US$/unit) Table 14. North America Piroxicam API Sales by Type (2021-2026) & (k units) Table 15. North America Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Piroxicam API Sales by Type (2021-2026) & (k units) Table 17. Europe Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Piroxicam API Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Piroxicam API Sales by Type (2021-2026) & (k units) Table 21. Latin America Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Piroxicam API Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Piroxicam API Sales by Type (2021-2026) & (US$ Million) Table 24. Piroxicam API Industry Trends Table 25. Piroxicam API Industry Drivers Table 26. Piroxicam API Industry Opportunities and Challenges Table 27. Piroxicam API Industry Restraints Table 28. Global Piroxicam API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Piroxicam API Revenue Market Share by Company (2021-2026) Table 30. Global Piroxicam API Sales by Company (2021-2026) & (k units) Table 31. Global Piroxicam API Sales Share by Company (2021-2026) Table 32. Global Piroxicam API Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Piroxicam API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Piroxicam API Major Company Production Sites and Headquarters Table 35. Global Piroxicam API Company, Product Type & Application Table 36. Global Piroxicam API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Piroxicam API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Piroxicam API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Piroxicam API Sales by Region (2021-2026) & (k units) Table 41. Global Piroxicam API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Piroxicam API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Piroxicam API Sales Market Share in Value by Region (2021-2026) Table 44. Global Piroxicam API Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Piroxicam API Sales by Region (2027-2032) & (k units) Table 46. Global Piroxicam API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Piroxicam API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Piroxicam API Sales Market Share in Value by Region (2027-2032) Table 49. Global Piroxicam API Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Piroxicam API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Piroxicam API Sales by Application (2021-2026) & (k units) Table 52. Global Piroxicam API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Piroxicam API Sales Market Share in Value by Application (2021-2026) Table 55. Global Piroxicam API Price by Application (2021-2026) & (US$/unit) Table 56. Global Piroxicam API Sales by Application (2027-2032) & (k units) Table 57. Global Piroxicam API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Piroxicam API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Piroxicam API Sales Market Share in Value by Application (2027-2032) Table 60. Global Piroxicam API Price by Application (2027-2032) & (US$/unit) Table 61. North America Piroxicam API Sales by Application (2021-2026) & (k units) Table 62. North America Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Piroxicam API Sales by Application (2021-2026) & (k units) Table 64. Europe Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Piroxicam API Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Piroxicam API Sales by Application (2021-2026) & (k units) Table 68. Latin America Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Piroxicam API Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Piroxicam API Sales by Application (2021-2026) & (US$ Million) Table 71. Nostrum Company Information Table 72. Nostrum Business Overview Table 73. Nostrum Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Nostrum Piroxicam API Product Portfolio Table 75. Nostrum Recent Development Table 76. SK Chemicals Company Information Table 77. SK Chemicals Business Overview Table 78. SK Chemicals Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. SK Chemicals Piroxicam API Product Portfolio Table 80. SK Chemicals Recent Development Table 81. Pidi Pharmaceutical Company Information Table 82. Pidi Pharmaceutical Business Overview Table 83. Pidi Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pidi Pharmaceutical Piroxicam API Product Portfolio Table 85. Pidi Pharmaceutical Recent Development Table 86. Pfizer Company Information Table 87. Pfizer Business Overview Table 88. Pfizer Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Pfizer Piroxicam API Product Portfolio Table 90. Pfizer Recent Development Table 91. Jumpcan Pharmaceutical Company Information Table 92. Jumpcan Pharmaceutical Business Overview Table 93. Jumpcan Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Jumpcan Pharmaceutical Piroxicam API Product Portfolio Table 95. Jumpcan Pharmaceutical Recent Development Table 96. Jiangxi Pharmaceutical Company Information Table 97. Jiangxi Pharmaceutical Business Overview Table 98. Jiangxi Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Jiangxi Pharmaceutical Piroxicam API Product Portfolio Table 100. Jiangxi Pharmaceutical Recent Development Table 101. Mylan Company Information Table 102. Mylan Business Overview Table 103. Mylan Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Mylan Piroxicam API Product Portfolio Table 105. Mylan Recent Development Table 106. Maoxiang Pharmaceutical Company Information Table 107. Maoxiang Pharmaceutical Business Overview Table 108. Maoxiang Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Maoxiang Pharmaceutical Piroxicam API Product Portfolio Table 110. Maoxiang Pharmaceutical Recent Development Table 111. Teva Company Information Table 112. Teva Business Overview Table 113. Teva Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Teva Piroxicam API Product Portfolio Table 115. Teva Recent Development Table 116. Viwit Pharmaceutical Company Information Table 117. Viwit Pharmaceutical Business Overview Table 118. Viwit Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Viwit Pharmaceutical Piroxicam API Product Portfolio Table 120. Viwit Pharmaceutical Recent Development Table 121. XinAn Pharmaceutical Company Information Table 122. XinAn Pharmaceutical Business Overview Table 123. XinAn Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. XinAn Pharmaceutical Piroxicam API Product Portfolio Table 125. XinAn Pharmaceutical Recent Development Table 126. Changjiang Pharmaceutical Company Information Table 127. Changjiang Pharmaceutical Business Overview Table 128. Changjiang Pharmaceutical Piroxicam API Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Changjiang Pharmaceutical Piroxicam API Product Portfolio Table 130. Changjiang Pharmaceutical Recent Development Table 131. North America Piroxicam API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. North America Piroxicam API Sales by Country (2021-2026) & (k units) Table 133. North America Piroxicam API Sales Market Share by Country (2021-2026) Table 134. North America Piroxicam API Sales Forecast by Country (2027-2032) & (k units) Table 135. North America Piroxicam API Sales Market Share Forecast by Country (2027-2032) Table 136. North America Piroxicam API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Piroxicam API Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Piroxicam API Market Share by Country (2021-2026) Table 139. North America Piroxicam API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Piroxicam API Market Share Forecast by Country (2027-2032) Table 141. Europe Piroxicam API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Europe Piroxicam API Sales by Country (2021-2026) & (k units) Table 143. Europe Piroxicam API Sales Market Share by Country (2021-2026) Table 144. Europe Piroxicam API Sales Forecast by Country (2027-2032) & (k units) Table 145. Europe Piroxicam API Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Piroxicam API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Piroxicam API Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Piroxicam API Market Share by Country (2021-2026) Table 149. Europe Piroxicam API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Piroxicam API Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Piroxicam API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Piroxicam API Sales by Country (2021-2026) & (k units) Table 153. Asia-Pacific Piroxicam API Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Piroxicam API Sales Forecast by Country (2027-2032) & (k units) Table 155. Asia-Pacific Piroxicam API Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Piroxicam API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Piroxicam API Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Piroxicam API Market Share by Country (2021-2026) Table 159. Asia-Pacific Piroxicam API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Piroxicam API Market Share Forecast by Country (2027-2032) Table 161. Latin America Piroxicam API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Latin America Piroxicam API Sales by Country (2021-2026) & (k units) Table 163. Latin America Piroxicam API Sales Market Share by Country (2021-2026) Table 164. Latin America Piroxicam API Sales Forecast by Country (2027-2032) & (k units) Table 165. Latin America Piroxicam API Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Piroxicam API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Piroxicam API Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Piroxicam API Market Share by Country (2021-2026) Table 169. Latin America Piroxicam API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Piroxicam API Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Piroxicam API Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Piroxicam API Sales by Country (2021-2026) & (k units) Table 173. Middle East and Africa Piroxicam API Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Piroxicam API Sales Forecast by Country (2027-2032) & (k units) Table 175. Middle East and Africa Piroxicam API Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Piroxicam API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Piroxicam API Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Piroxicam API Market Share by Country (2021-2026) Table 179. Middle East and Africa Piroxicam API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Piroxicam API Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Piroxicam API Distributors List Table 184. Piroxicam API Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Piroxicam API Image Figure 2. Global Piroxicam API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Piroxicam API Market Size (2021-2032) & (US$ Million) Figure 4. Global Piroxicam API Sales (2021-2032) & (k units) Figure 5. Purity≥ 99% Image Figure 6. Global Purity≥ 99% Sales YoY Growth (2021-2032) & (k units) Figure 7. Purity≥ 99.5% Image Figure 8. Global Purity≥ 99.5% Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Piroxicam API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Piroxicam API Market Share by Type 2025 VS 2032 Figure 11. North America Piroxicam API Sales Market Share in Volume by Type in 2025 Figure 12. North America Piroxicam API Sales Market Share in Value by Type in 2025 Figure 13. Europe Piroxicam API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Piroxicam API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Piroxicam API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Piroxicam API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Piroxicam API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Piroxicam API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Piroxicam API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Piroxicam API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Piroxicam API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Injection Image Figure 24. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 25. Ointment Image Figure 26. Global Ointment Sales YoY Growth (2021-2032) & (k units) Figure 27. Tablets Image Figure 28. Global Tablets Sales YoY Growth (2021-2032) & (k units) Figure 29. Capsule Image Figure 30. Global Capsule Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Piroxicam API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Piroxicam API Market Share by Application 2025 VS 2032 Figure 33. North America Piroxicam API Sales Market Share in Volume by Application in 2025 Figure 34. North America Piroxicam API Sales Market Share in Value by Application in 2025 Figure 35. Europe Piroxicam API Sales Market Share in Volume by Application in 2025 Figure 36. Europe Piroxicam API Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Piroxicam API Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Piroxicam API Sales Market Share in Value by Application in 2025 Figure 39. Latin America Piroxicam API Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Piroxicam API Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Piroxicam API Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Piroxicam API Sales Market Share in Value by Application in 2025 Figure 43. North America Piroxicam API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Piroxicam API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Piroxicam API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Piroxicam API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Piroxicam API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Piroxicam API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Piroxicam API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Piroxicam API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Piroxicam API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Piroxicam API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Piroxicam API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Piroxicam API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Piroxicam API Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Piroxicam API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Piroxicam API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Piroxicam API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Piroxicam API Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Piroxicam API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥ 99%
  • Purity≥ 99.5%
Applications
  • Injection
  • Ointment
  • Tablets
  • Capsule
Companies covered
  • Nostrum
  • SK Chemicals
  • Pidi Pharmaceutical
  • Pfizer
  • Jumpcan Pharmaceutical
  • Jiangxi Pharmaceutical
  • Mylan
  • Maoxiang Pharmaceutical
  • Teva
  • Viwit Pharmaceutical
  • XinAn Pharmaceutical
  • Changjiang Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Piroxicam API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Piroxicam API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Piroxicam API Market by Type
  6. 1.3.1 Purity≥ 99%
  7. 1.3.2 Purity≥ 99.5%
  8. 1.4 Global Piroxicam API Market Size by Type
  9. 1.4.1 Global Piroxicam API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Piroxicam API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Piroxicam API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Piroxicam API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Piroxicam API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Piroxicam API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Piroxicam API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Piroxicam API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Piroxicam API Industry Trends
  2. 2.2 Piroxicam API Industry Drivers
  3. 2.3 Piroxicam API Industry Opportunities and Challenges
  4. 2.4 Piroxicam API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Piroxicam API Revenue (2021-2026)
  2. 3.2 Global Top Players by Piroxicam API Sales (2021-2026)
  3. 3.3 Global Top Players by Piroxicam API Price (2021-2026)
  4. 3.4 Global Piroxicam API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Piroxicam API Major Company Production Sites & Headquarters
  6. 3.6 Global Piroxicam API Company, Product Type & Application
  7. 3.7 Global Piroxicam API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Piroxicam API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Piroxicam API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Piroxicam API Tier 1, Tier 2, and Tier 3
4 Piroxicam API Regional Status and Outlook
  1. 4.1 Global Piroxicam API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Piroxicam API Historic Market Size by Region
  3. 4.2.1 Global Piroxicam API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Piroxicam API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Piroxicam API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Piroxicam API Forecasted Market Size by Region
  7. 4.3.1 Global Piroxicam API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Piroxicam API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Piroxicam API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Piroxicam API by Application
  1. 5.1 Piroxicam API Market by Application
  2. 5.1.1 Injection
  3. 5.1.2 Ointment
  4. 5.1.3 Tablets
  5. 5.1.4 Capsule
  6. 5.2 Global Piroxicam API Market Size by Application
  7. 5.2.1 Global Piroxicam API Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Piroxicam API Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Piroxicam API Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Piroxicam API Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Piroxicam API Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Piroxicam API Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Piroxicam API Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Piroxicam API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Nostrum
  2. 6.1.1 Nostrum Company Information
  3. 6.1.2 Nostrum Business Overview
  4. 6.1.3 Nostrum Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Nostrum Piroxicam API Product Portfolio
  6. 6.1.5 Nostrum Recent Developments
  7. 6.2 SK Chemicals
  8. 6.2.1 SK Chemicals Company Information
  9. 6.2.2 SK Chemicals Business Overview
  10. 6.2.3 SK Chemicals Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 SK Chemicals Piroxicam API Product Portfolio
  12. 6.2.5 SK Chemicals Recent Developments
  13. 6.3 Pidi Pharmaceutical
  14. 6.3.1 Pidi Pharmaceutical Company Information
  15. 6.3.2 Pidi Pharmaceutical Business Overview
  16. 6.3.3 Pidi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Pidi Pharmaceutical Piroxicam API Product Portfolio
  18. 6.3.5 Pidi Pharmaceutical Recent Developments
  19. 6.4 Pfizer
  20. 6.4.1 Pfizer Company Information
  21. 6.4.2 Pfizer Business Overview
  22. 6.4.3 Pfizer Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Piroxicam API Product Portfolio
  24. 6.4.5 Pfizer Recent Developments
  25. 6.5 Jumpcan Pharmaceutical
  26. 6.5.1 Jumpcan Pharmaceutical Company Information
  27. 6.5.2 Jumpcan Pharmaceutical Business Overview
  28. 6.5.3 Jumpcan Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Jumpcan Pharmaceutical Piroxicam API Product Portfolio
  30. 6.5.5 Jumpcan Pharmaceutical Recent Developments
  31. 6.6 Jiangxi Pharmaceutical
  32. 6.6.1 Jiangxi Pharmaceutical Company Information
  33. 6.6.2 Jiangxi Pharmaceutical Business Overview
  34. 6.6.3 Jiangxi Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jiangxi Pharmaceutical Piroxicam API Product Portfolio
  36. 6.6.5 Jiangxi Pharmaceutical Recent Developments
  37. 6.7 Mylan
  38. 6.7.1 Mylan Company Information
  39. 6.7.2 Mylan Business Overview
  40. 6.7.3 Mylan Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Mylan Piroxicam API Product Portfolio
  42. 6.7.5 Mylan Recent Developments
  43. 6.8 Maoxiang Pharmaceutical
  44. 6.8.1 Maoxiang Pharmaceutical Company Information
  45. 6.8.2 Maoxiang Pharmaceutical Business Overview
  46. 6.8.3 Maoxiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Maoxiang Pharmaceutical Piroxicam API Product Portfolio
  48. 6.8.5 Maoxiang Pharmaceutical Recent Developments
  49. 6.9 Teva
  50. 6.9.1 Teva Company Information
  51. 6.9.2 Teva Business Overview
  52. 6.9.3 Teva Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Teva Piroxicam API Product Portfolio
  54. 6.9.5 Teva Recent Developments
  55. 6.10 Viwit Pharmaceutical
  56. 6.10.1 Viwit Pharmaceutical Company Information
  57. 6.10.2 Viwit Pharmaceutical Business Overview
  58. 6.10.3 Viwit Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Viwit Pharmaceutical Piroxicam API Product Portfolio
  60. 6.10.5 Viwit Pharmaceutical Recent Developments
  61. 6.11 XinAn Pharmaceutical
  62. 6.11.1 XinAn Pharmaceutical Company Information
  63. 6.11.2 XinAn Pharmaceutical Business Overview
  64. 6.11.3 XinAn Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 XinAn Pharmaceutical Piroxicam API Product Portfolio
  66. 6.11.5 XinAn Pharmaceutical Recent Developments
  67. 6.12 Changjiang Pharmaceutical
  68. 6.12.1 Changjiang Pharmaceutical Company Information
  69. 6.12.2 Changjiang Pharmaceutical Business Overview
  70. 6.12.3 Changjiang Pharmaceutical Piroxicam API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Changjiang Pharmaceutical Piroxicam API Product Portfolio
  72. 6.12.5 Changjiang Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Piroxicam API Sales by Country
  2. 7.1.1 North America Piroxicam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Piroxicam API Sales by Country (2021-2026)
  4. 7.1.3 North America Piroxicam API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Piroxicam API Market Size by Country
  6. 7.2.1 North America Piroxicam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Piroxicam API Market Size by Country (2021-2026)
  8. 7.2.3 North America Piroxicam API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Piroxicam API Sales by Country
  2. 8.1.1 Europe Piroxicam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Piroxicam API Sales by Country (2021-2026)
  4. 8.1.3 Europe Piroxicam API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Piroxicam API Market Size by Country
  6. 8.2.1 Europe Piroxicam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Piroxicam API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Piroxicam API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Piroxicam API Sales by Country
  2. 9.1.1 Asia-Pacific Piroxicam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Piroxicam API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Piroxicam API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Piroxicam API Market Size by Country
  6. 9.2.1 Asia-Pacific Piroxicam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Piroxicam API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Piroxicam API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Piroxicam API Sales by Country
  2. 10.1.1 South America Piroxicam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Piroxicam API Sales by Country (2021-2026)
  4. 10.1.3 South America Piroxicam API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Piroxicam API Market Size by Country
  6. 10.2.1 South America Piroxicam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Piroxicam API Market Size by Country (2021-2026)
  8. 10.2.3 South America Piroxicam API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Piroxicam API Sales by Country
  2. 11.1.1 Middle East and Africa Piroxicam API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Piroxicam API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Piroxicam API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Piroxicam API Market Size by Country
  6. 11.2.1 Middle East and Africa Piroxicam API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Piroxicam API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Piroxicam API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Piroxicam API Value Chain Analysis
  2. 12.1.1 Piroxicam API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Piroxicam API Production Mode & Process
  7. 12.2 Piroxicam API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Piroxicam API Distributors
  10. 12.2.3 Piroxicam API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst